“cell-therapy” Archives

in
Entry Author Date Location
SQZ Biotech Lines Up an IPO on the NYSE to Fund Cell Therapy R&D 10/12/20 Boston
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy 09/15/20 Europe
Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold 08/18/20 San Diego
GlaxoSmithKline Multiple Myeloma Drug Earns FDA’s First Anti-BCMA Nod 08/06/20 National
GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology 08/05/20 Boston
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
AlloVir’s IPO Raises $276M to Test Cell Therapies in Transplant Patients 07/30/20 Boston
Vesigen Nabs $28M to Wrap “ARMMS” Around Large Molecule Drug Delivery 07/22/20 Boston
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments 07/13/20 National
Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs 07/07/20 Boston
Artiva Bio Raises $78M to Broaden Access to Cancer Cell Therapies 06/26/20 San Diego
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products 06/25/20 National
Timing Is an Essential Element of Cell & Gene Therapy Product Development 06/19/20 Philadelphia
Orca Bio Surfaces With $192M and Recipes for “Custom” Cell Therapies 06/17/20 San Francisco
Legend Biotech’s Upsized IPO Lands $424M for Multiple Myeloma Drug 06/05/20 New York
From Overseas, Legend Biotech and Calliditas Therapeutics Eye the Nasdaq 05/15/20 New York
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System 05/14/20 New York
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies 05/12/20 San Francisco
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Adicet Aims to Advance CAR-T Therapies in Reverse Merger with resTORbio 04/29/20 Boston
Synthorx’s Shawver Joins Silverback Therapeutics as New Top Exec 04/22/20 Seattle
Fate Inks $100M Deal With Janssen for Stem Cell-Derived Cancer Therapies 04/03/20 San Diego
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Celularity to Test Natural Killer Cell Therapy for Cancer Against COVID 04/02/20 National
Eureka Partners With Lyell to Tackle Tricky Solid Tumor Cell Therapies 03/20/20 San Francisco
Rubius Drops Rare Diseases, Turns to Cancer and Autoimmune Disorders 03/12/20 Boston
Gilead Boosts Cancer Drug Pipeline With $4.9B Deal for Forty Seven 03/02/20 San Francisco
Sonoma Bio Launches With $40M to Take Cell Therapy Beyond Cancer 02/06/20 San Francisco
Scripps Research’s Calibr to Test “Switchable” CAR-T in Clinical Trial 02/06/20 San Diego
Page 1 of 4 next page »